Piper Sandler raised its estimate for MetLife's stock and kept its favorable rating, a positive sign for the shares. This is one firm's view, not new evidence about MetLife's sales or profits, so the signal is limited.
That change reflects a more favorable estimate from one investment firm, not a change in MetLife's sales or profits. It supports a positive read, but adds no new proof about how the business is doing.
Follow MetLife, Inc. (MET) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MET